Connect with us

Technology

AAC Technologies’s CFO Guo Dan: Expects 15% Growth in Revenue of Main Business while the Growth of the Group May Exceeds 30% After PSS Consolidation

Published

on

HONG KONG, Aug. 27, 2024 /PRNewswire/ — On August 22, AAC Technologies (02018.HK) held its 2024 interim results presentation in Hong Kong, delivering remarkably impressive performance.

According to the Interim Report, in the first half of 2024, AAC Technologies achieved a revenue of RMB 11.25 billion, hitting a new high since its listing, with a year-on-year revenue growth of 22.0% and a gross profit margin of 21.5%, up by 7.4 percentage points year-on-year. The net profit amounted to RMB 537 million, representing a significant increase of 257.3% year-on-year. Notably, PSS, which was announced to acquire last year, contributed a consolidated revenue of approximately RMB 1.5 billion in the first half of the year, with a gross profit margin of approximately 25.0%.

During the interview, Ms. Guo Dan, the CFO of AAC Technologies stated that in the first half of 2024, all business segments of AAC Technologies made positive progress, significantly enhancing profitability and maintaining a continuous growth in gross profit margin. More importantly, the performance of the interim results indicated the potential growth value brought by the Company’s strategic transformation. It is expected that the operating revenue of the Group (excluding PSS) for the year will increase by 15% compared to last year. Additionally, the consolidation of PSS is expected to contribute approximately RMB 3 billion. Overall, the total revenue of the Group for 2024 is projected to grow by over 30% year-on-year, with a gross profit margin in the range of 22% to 25%.

Benefitting from the surge in AI smartphone upgrades in the next 1-2 years

At the interim results presentation, AI smartphones took center stage as a key topic. Guo Dan believes that AI smartphones are still in the early stages, with software-driven enhancements propelling hardware upgrades. There has already been a trend of increased shipments and overall improvement in ASP for product categories such as acoustics, mechanics and microphones. Looking ahead, with the further development of AI smartphones and functionalities, hardware component is expected to continue to advance in the coming years.

“AI smartphones have great potential for innovation. In the next 1-2 years, we will see some changes, with an acceleration of changes in the 3-5 year period, bringing us many opportunities and driving multiple product lines,” Guo Dan stated. She cited examples such as new trends in hardware like foldable and ultra-thin form factors, and the Company’s unique innovative speakers, and Combo (two-in-one product, which integrates a speaker and an actuator) can better meet market demands.

Moreover, AI smartphones have higher power consumption and require better heat dissipation solutions. AAC Technologies has industry-leading advantages from material sourcing to lean manufacturing processes and simulation design. Additionally, as the demand for human-machine interaction in AI smartphones increases, requiring more precise voice commands and functionalities, this will further drive the Company’s MEMS microphone upgrades, boosting prices and profit margins.

The Group’s overall gross profit margin is expected to increase to 22%-25% for FY2024

Guo Dan revealed that with the seasonal impact of more new product releases in the second half of the year, performance is expected to be stronger than the first half. It is anticipated that the full-year business performance (excluding PSS) will achieve a growth of over 15% compared to last year. With PSS contributing approximately RMB 3 billion, the Group’s revenue in 2024 is projected to grow by over 30% year-on-year, with the comprehensive gross profit margin increasing from 21.5% in the first half of the year to a range of 22%-25%.

“Since the second half of last year, the entire industry has entered a healthy trend of increasing specifications and configurations. The Company has seen improvements in ASP and overall profit margins in areas such as acoustics, optics, and mechanics,” Guo Dan stated. Particularly in the automotive sector, there will be a steady growth trend in the medium to long term. “It can be said that AAC is now a company with multiple growth drivers and solutions across various platforms. As we forecast the overall growth for the next few years, we maintain a positive outlook.”

The acoustics business is expected to exceed a scale of RMB 10 billion and build a comprehensive user experience across all scenarios

Guo Dan mentioned that the gross profit margin of AAC Technologies’ acoustics business has resumed to a healthy growth trajectory. The gross profit margin in the first half of the year was 29.9%, and it is expected to rise to over 30% for the full year.

“At the interim results presentation, the Company’s management also discussed how AAC Technologies, originally a micro-acoustic supplier for consumer electronics, has further established industry standards for a comprehensive user experience across all scenarios through the acquisition of PSS. Acoustic solutions will be a key driver for the next phase of growth in the acoustics business. In terms of scale, the acoustics business is the Company’s first to exceed a revenue scale of over RMB 10 billion, and in the next five years, we can expect this important business line with a revenue scale of RMB 20 billion and a sustainable gross profit margin of over 30%.”

Definite progress in the WLG projects of multiple key customers

In terms of the optics business, Guo Dan believes that the optics market has transitioned from a relatively competitive state a few years ago to a period of healthy development.

The gross profit margin for optics in the first half of the year was approximately 5%, with plastic lens gross profit margin at 16-17%. Shipments of 6P and higher specification lenses accounted for 15%-16% of total shipments, with expectations of reaching 15-20% in the second half of the year. “In terms of value, it has already surpassed 30% or even 35%, which reflects our technical capabilities, customer coverage, and recognition.”

Guo Dan disclosed that AAC Technologies’ gross profit for optics will further improve in the second half of the year. “It is foreseeable that the profit for a single quarter will turn positive, with a high probability of occurring in the fourth quarter. Overall profitability will see significant improvement compared to last year, with continued steady growth in the future.”

“Especially with G+P glass-plastic hybrid lenses and WLG lens products, there have been definite advancements in major projects with several key customers,” Guo Dan stated. The industry now widely acknowledges that G+P glass-plastic hybrid lenses are indeed a superior solution. The Company’s unique WLG technology finds applications in areas such as smartphones and automotive, creating value across multiple domains. “Next year, G+P glass-plastic lenses and WLG single lenses will gradually become one of the most crucial technologies and value supports in the entire optics business, with many deliveries to customers aligning with our expectations for WLG technology investments.”

The interim results performance reflects the Company’s long-term growth value

“Looking at the first half of this year, the electromagnetic actuators and haptic business have already reached a gross profit margin of approximately 30% with the optimization and upgrade of product portfolios on the Android side, and this healthy level is expected to be sustained in the future,” Guo Dan stated. With the boost from the development of new products like actuators and drives, this sector is poised to return to a high-growth trajectory.

“At the interim results presentation, the Company’s management also mentioned that in the heat dissipation segment, AAC Technologies achieved a business scale of RMB 150 million in the first half of the year, with a gross profit margin of over 30%. With the development of AI-enabled applications, the scale is expected to exceed RMB 1 billion in the future. When combined with precision mechanics, the overall scale could reach RMB 5 billion and potentially even surpass RMB 10 billion in the long term.”

“Additionally, the overall gross profit for the sensor and semiconductor business will continue to increase in the second half of the year,” Guo Dan mentioned. Over the next two to three years, driven by factors such as the value enhancement brought by AI smartphones, the advantages brought by the Company’s resource platform, and the increase in self-developed product penetration rates, the sensor and semiconductor business is expected to experience rapid development.

Guo Dan concluded, “At the interim results presentation, the management also pointed out that this performance has shown investors that AAC has achieved revenue growth, as well as gross and net profit improvements through strategic transformation at the current stage. However, more importantly, the interim results implied the long-term growth value of each major business line, and we encourage everyone to focus on the certainty of sustained long-term growth.”

CONTACT: Bunny Lee, bunny.lee@pordahavas.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/aac-technologiess-cfo-guo-dan-expects-15-growth-in-revenue-of-main-business-while-the-growth-of-the-group-may-exceeds-30-after-pss-consolidation-302231681.html

SOURCE AAC Technologies

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple

Published

on

By

The article explains how sterile compounded medications are prepared to reduce the risk of contamination and support safe, customized treatments.

AZLE, Texas, July 21, 2026 /PRNewswire/ — What does sterile compounding mean for medication safety? HelloNation has published an article explaining how sterile compounding helps pharmacies prepare highly specialized medications while adhering to strict contamination-prevention procedures.

The article features insights from Laura Temple, Compounding Pharmacist Expert and Owner of Laura’s Pharmacy in Azle, Texas. It explains that sterile compounding is a specialized process for preparing medications in carefully controlled environments designed to reduce the risk of contamination. Sterile compounded medications are often used for injections, eye drops, IV medications, and other therapies that require the highest levels of cleanliness and precision.

The HelloNation article explains that sterile compounded medications differ from commercially manufactured drugs because they are prepared individually for a patient’s unique medical needs. Physicians may prescribe compounded prescriptions when a patient requires a customized dosage, a combination medication, or a treatment not commercially available. Because these medications often bypass the body’s natural defenses, medication safety depends on strict preparation standards throughout the compounding process.

The article describes how pharmacies that provide sterile compounding rely on cleanroom environments equipped with filtered-air systems, specialized equipment, and contamination-prevention protocols. Pharmacists and technicians follow detailed gowning, sterilization, and handwashing procedures before handling medication ingredients. These measures are designed to support medication safety by limiting exposure to bacteria, particles, and other contaminants.

According to the article, environmental monitoring also plays a critical role in sterile compounding. Temperature control, air quality testing, and routine equipment inspections help maintain consistent preparation standards. The article notes that sterile compounded medications may undergo additional quality assurance checks before being dispensed to patients. These procedures help support both treatment effectiveness and patient safety.

The HelloNation article also explains that pharmacies performing sterile compounding are expected to follow USP guidelines established for sterile preparation. These USP guidelines outline requirements for cleanroom pharmacy operations, environmental testing, employee training, and quality assurance practices. The article emphasizes that maintaining compliance with USP guidelines helps reinforce contamination prevention and consistent preparation standards for compounded prescriptions.

Patients seeking sterile compounded medications may also look for pharmacies that participate in accreditation programs or are overseen by state boards. The article explains that these programs review safety procedures, documentation practices, and facility standards to help maintain medication safety. Regular environmental monitoring and staff competency evaluations are also identified as important safeguards in sterile compounding operations.

The article further explains that communication between pharmacists, healthcare providers, and patients remains an important part of safe compounded prescriptions. Compounding pharmacists review prescriptions carefully, confirm dosing instructions, and evaluate ingredient compatibility before preparation begins. This collaborative approach supports medication safety by reducing the risk of errors and ensuring treatments meet individual patient needs.

The article concludes that sterile compounding continues to play an important role in healthcare, particularly for patients requiring customized therapies that are unavailable through traditional manufacturing channels. Whether preparing IV medications, injectable therapies, or other sterile compounded medications, pharmacies rely on contamination prevention procedures and strict preparation standards to support patient care. The article notes that understanding how sterile compounding works can help patients feel more informed about the safety measures involved in preparing specialized medications.

What Sterile Compounding Means for Medication Safety features insights from Laura Temple, a compounding pharmacist expert at Laura’s Pharmacy in Azle, Texas, on HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-article-highlights-sterile-compounding-and-medication-safety-with-insights-from-compounding-pharmacist-expert-laura-temple-302831275.html

SOURCE HelloNation

Continue Reading

Technology

CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group

Published

on

By

Regulatory demands are increasing in volume, complexity, and speed, leaving many organizations reliant on fragmented, manual approaches that slow response times and increase risk. New insights from Info-Tech Research Group show that organizations need to adopt more structured and scalable approaches to keep pace with regulatory change. The firm’s recently published blueprint, Build a Regulatory IT Response Engine, provides frameworks, tools, and step-by-step guidance to help organizations translate regulatory requirements into actionable IT controls and prioritized initiatives.

ARLINGTON, Va., July 21, 2026 /PRNewswire/ — Growing regulatory pressure across jurisdictions is forcing organizations to rethink how they interpret, prioritize, and execute compliance requirements. Many IT teams continue to operate with inconsistent processes and limited coordination, resulting in delayed initiatives and increased exposure to financial and reputational risk. Info-Tech’s blueprint, Build a Regulatory IT Response Engine, introduces a coordinated and repeatable approach to help IT leaders operationalize compliance and improve execution outcomes.

Info-Tech’s findings indicate that while organizations recognize the need for faster and more consistent regulatory response, they continue to face barriers such as fragmented interpretation of requirements, weak prioritization, and limited scalability. AI-enabled tools can help streamline analysis and accelerate response planning, but without a coordinated approach grounded in governance and human oversight, those benefits are difficult to realize.

“Regulatory response is becoming too complex to manage through disconnected, manual processes,” says Ahmad Jowhar, senior research analyst at Info-Tech Research Group. “IT leaders need a repeatable way to interpret requirements, prioritize action, and use AI to accelerate planning without losing the governance and oversight needed to execute effectively.”

Key Challenges IT Leaders Face in Regulatory Response

Despite ongoing investments in compliance, organizations continue to face systemic challenges that hinder effective execution. Info-Tech’s blueprint highlights several areas where IT and compliance leaders struggle most:

Fragmented and manual processes that slow regulatory interpretation and response.Inconsistent application of regulatory requirements across teams and jurisdictions.Poor prioritization of IT initiatives, leading to missed deadlines and duplicated effort.Limited scalability to manage increasing regulatory volume and complexity.Misalignment between compliance activities and broader business priorities.

Info-Tech’s Framework for Building a Regulatory IT Response Engine

To address these challenges, Info-Tech recommends a structured, AI-enabled approach that improves consistency, speed, and scalability. The firm’s Build a Regulatory IT Response Engine blueprint outlines the following key priorities for IT leaders:

Define the regulatory landscape: Establish organizational context, governance structures, and a centralized inventory of applicable regulations.Translate requirements into IT controls: Use AI-enabled analysis and structured assessments to convert regulatory obligations into actionable controls.Prioritize IT initiatives: Align initiatives based on cost, effort, impact, and regulatory timelines to reduce execution risk.Build and communicate a roadmap: Develop a clear, resource-aligned roadmap to guide execution and stakeholder alignment.Establish a repeatable process: Continuously monitor, adapt, and refine regulatory response capabilities to maintain compliance over time.

Organizations that adopt this structured approach can move from reactive compliance efforts to a more proactive and scalable model that shortens response timelines, reduces manual effort, and strengthens execution.

The firm’s Build a Regulatory IT Response Engine blueprint includes practical tools such as a Regulation Inventory Tool, a Regulatory Response IT Action Plan Tool, a Communication Deck Template, and a Compliance Program Framework. By applying these resources, IT leaders can standardize regulatory responses, improve prioritization, and help ensure compliance initiatives are executed on time and in alignment with business priorities.

For exclusive and timely commentary from Info-Tech’s experts, including Ahmad Jowhar, and access to the complete Build a Regulatory IT Response Engine blueprint, please contact pr@infotech.com.

About Info-Tech Research Group

Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.

To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.

Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.

For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cios-forced-to-rethink-manual-compliance-processes-as-regulatory-complexity-rises-says-info-tech-research-group-302831286.html

SOURCE Info-Tech Research Group

Continue Reading

Technology

Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026

Published

on

By

LOS GATOS, Calif., July 21, 2026 /PRNewswire/ — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, announced today that it plans to release its second quarter 2026 financial results after the market closes on Tuesday, Aug. 4, 2026.

The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, Aug. 4, 2026, to discuss the results. The live webinar can be accessed through Atomera’s investor relations website at https://ir.atomera.com. A replay of the webcast will be available for 12 months. To pre-register for the webinar, use the following link.

https://atomera.zoom.us/webinar/register/WN_OJFbTWe1SIyV69LLdDadCw

About Atomera

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.  More information can be found at www.atomera.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-to-announce-second-quarter-2026-financial-results-and-host-webinar-on-tuesday-august-4-2026-302830602.html

SOURCE Atomera Incorporated

Continue Reading

Trending